Victor Chen is a partner in Goodwin’s Private Equity group. Mr. Chen represents private equity sponsors, multinational corporations and institutional investors in their M&A transactions and investments, with a particular focus on Asia cross-border deals. He has extensive experience advising private equity, venture and institutional investors in their Greater China and U.S. transactions, including public and private mergers and acquisitions, securities offerings, financings, PIPEs and auctions in a wide variety of industries.

Mr. Chen’s practice also involves all aspects of corporate advisory work. Mr. Chen has been active in a number of going-private transactions and has advised founders, special committees, private equity sponsors and financial advisers in these transactions.

Prior to joining Goodwin in 2017, Mr. Chen was a partner in the Hong Kong office of Paul Hastings, and previously practiced at Fried Frank and O’Melveny & Meyers.

陈昶元律师是高赢国际律师事务所私募股权部的合伙人。陈律师在并购交易及投资中担任私募股权保荐人、跨国企业及全球投资银行机构的代表律师,善于处理亚洲市场跨境交易。他在涉华及涉美交易方面拥有丰富经验,就公开及私人合并、证券发售、融资、私人投资公开股票及竞拍等事务,为私募股权公司、创投和投资银行提供法律咨询。

陈律师的业务也涉及企业咨询工作的各个方面。陈律师一直积极参与多项私有化交易,并在这些交易中为创始人,特别委员会,私募股权发起人和财务顾问提供咨询服务。

在2017年加入高赢之前,陈律师是美国普衡律师事务所合伙人,也曾于法朗克律师行和美迈斯律师事务所执业。

Areas of Practice
TÄTIGKEITSFELDER
Domaines D’Expertise
业务范围

Experience

ERFAHRUNG

EXPÉRIENCE

工作经历

Mr. Chen has served as counsel to:

  • FountainVest Partners in connection with its going private acquisition of Chinese online career platform Zhaopin Limited, together with Hillhouse Capital and SEEK International*
  • FountainVest Partners in a number of transactions, including its establishment of a joint venture in China with WME | IMG, a global sports, fashion and entertainment talent management company, together with Sequoia Capital China and Tencent, and its investments in leading China-based businesses, including Meituan-Dianping, Fangdd.com, and Codoon*
  • ZQ Capital its acquisition of Angiotech Pharmaceuticals, Inc., a medical device manufacturer, and its $210 million PIPE investment in NYSE-listed Nu Skin Enterprises*
  • Horizons Ventures Limited, the private investment arm of Li Ka-Shing, in its investments in numerous early-stage technology companies based in the U.S. and Canada*
  • Co-investment fund formed by Focus Media and FountainVest Partners in connection with investments in the sports, media and entertainment industries*
  • TOM Group Limited, in their investments in WeLab Holdings (WeLend) and Rubikloud Technologies Inc.*
  • China Media Capital and FountainVest Partners in their investment in the Greater China business of large-screen movie exhibitor IMAX Corp. (awarded “Mid-Cap Deal of the Year” by Asian Venture Capital Journal (2014)) and the sale of their shares in the Hong Kong IPO of IMAX China*
  • the buyer group (including the Carlyle Group, FountainVest Partners, and CITIC Capital Partners) in connection with the US$3.7 billion acquisition of Focus Media, China’s then-largest leveraged buy-out (awarded “Global M&A Deal of the Year: China Private Equity” by The American Lawyer (2014) and “Private Equity Deal of the Year” by IFLR (2014) and China Law & Practice (2013))*
  • LionRock Capital in connection with numerous transactions*
  • Goldman Sachs as financial adviser to the Special Committee of NASDAQ-listed AsiaInfo-Linkage in a US$890 million going-private acquisition led by CITIC Capital Partners*
  • Lazard as financial adviser to the buyer group in its going-private acquisition of NASDAQ-listed Yucheng Technologies Limited*
  • the private equity buyer consortium in its going-private acquisition of China jewelry retailer and distributor NASDAQ-listed LJ International*
  • the Special Committee of NASDAQ-listed CNinsure in connection with a proposed US$950 million going-private transaction involving its chairman and private equity sponsors, including TPG*
  • the independent board of NYSE-listed Acorn International, a China-based TV retailer, in connection with its consideration of an unsolicited partial tender offer by its co-founders*
  • the founder and controlling shareholder of Tiens Biotech Group in a going-private squeeze-out merger transaction*
  • the Special Committee of Board of Directors of NASDAQ-listed Solarfun Power Holdings, a solar cell producer, in connection with its US$370 million sale of a controlling stake to Hanwha Corporation*
  • Sequoia Capital, Citic Capital and FountainVest Partners in a US$180 million PIPE investment in NASDAQ-listed SINA Corporation*
  • NYSE-listed WuXi Pharmatech, a leading Chinese R&D outsourcing company, in its announced (and subsequently terminated) acquisition by Charles River Laboratories for US$1.6 billion*
  • NYSE-listed Mindray Medical International Limited, a China-based medical device company, in its US$202 million acquisition of the worldwide patient monitoring business of Datascope, creating the then-third-largest player in the global patient monitoring industry*

* Denotes experience prior to joining Goodwin.

  • 代表方源资本,处理其联合高瓴资本及SEEK International对中国招聘网站智联招聘进行私有化的交易。*
  • 代表方源资本处理多宗交易,包括联合红杉资本和腾讯与全球体育、时尚娱乐经纪公司WME-IMG在中国设立合资公司,以及其对包括美团点评、房多多和咕咚网在内的主要中资企业所进行的投资。*
  • 代表倍哲资本处理其收购医疗器械制造商Angiotech Pharmaceuticals的交易,以及其对纽约上市的如新企业(Nu Skin Enterprises)进行的私人投资公开股票(PIPE)交易。*
  • 代表李嘉诚旗下的维港投资投资于美国和加拿大的多家早期技术公司。*
  • 代表分众传媒与方源资本成立的共同投资基金,处理其在运动、传媒和娱乐行业的投资交易。*
  • 代表TOM集团投资于WeLab Holdings(WeLend)和Rubikloud Technologies Inc.。*
  • 代表华人文化产业投资基金和方源资本投资于大屏幕电影参展商IMAX Corp.的大中华业务(该交易获得《亚洲创业投资期刊》(2014)评为的“年度最佳中型交易”)以及在IMAX中国的香港首次公开募股中出售持有的股份。*
  • 为买方银团(由凯雷、方源资本、中信资本、光大控股、复星国际和公司主席组成)提供咨询服务,协助处理其作价37亿美元收购分众传媒控股有限公司(纳斯达克上市代号:FMCN)的事宜。此私有化交易是中国历来最大型的杠杆收购(该交易获《美国律师》杂志评为2014年度“全球年度最佳中国私募股权并购交易”,并获《全球金融法律评论》杂志和《中国法律商务》杂志分别评为2014年度及2013年度“最佳私募股权交易“。*
  • 代表莱恩资本处理其多项交易。*
  • 代表亚信联创(纳斯达克上市代号:ASIA) 特别委员会的财务顾问高盛公司,协助其处理由中信资本牵头的财团作价8.9亿美元对亚信联创进行的收购。*
  • 为担任买方集团财务顾问的瑞德集团提供咨询服务,协助其处理买方集团收购宇信易诚科技有限公司(纳斯达克上市代号:YTEC)的事宜。*
  • 代表私募股权银团,协助其处理私有化于纳斯达克上市的中资珠宝零售商和分销商LJ国际有限公司的事宜。*
  • 代表泛华保险服务(纳斯达克上市代号:CISG) 特别委员会,协助处理拟进行并涉及其董事长及私募股权保荐人 (包括德州太平洋集团 (TPG)) 的私有化交易,价值9.5亿美元。*
  • 为中资电视营销商橡果国际(纽约上市代号:ATV)独立董事会提供咨询服务,协助该公司处理其考虑是否接受由其共同创办人主动提出的部分收购要约。*
  • 代表天狮生化的控股股东处理天狮生化的私有化交易。*
  • 代表纳斯达克上市的太阳能电池制造商林洋新能源控股特别委员会,协助其处理向韩华集团作价3.7亿美元出售控股股权的事宜。*
  • 为红杉资本、中信资本及方源资本提供咨询服务,协助处理其对新浪公司进行的1.8亿美元投资。*
  • 为在纽约上市的中国大型研发外包服务公司药明康德(WuXi Pharmatech)提供咨询服务,协助处理其宣布(及其后遭终止)由 Charles River Laboratories 进行收购的事宜,价值 16 亿美元。*
  • 为在纽约上市的中资医疗器械生产商迈瑞医疗国际股份有限公司(Mindray Medical International Limited)提供咨询服务,协助处理其以 2.02 亿美元收购 Datascope 的全球病人监护业务,从而成为全球病人监护行业中第三大企业。*

*代表加入高赢之前办理的交易

Recognition

Recognized in The Legal 500 Asia Pacific (2015) as one of the “prominent names in the Asia private equity scene” and noted for his ability to “think outside the box” and “find novel solutions.”

荣誉奖励

获《亚太法律500强》评为2015年“亚洲私募股权领域的知名律师”之一,他以“超越思维”和“寻找新颖解决方案”的能力而闻名。

In The News

MELDUNGEN

ACTUALITÉS

相关新闻

Credentials

WERDEGANG

RÉFÉRENCES

专业资格

Education

J.D., 2000
The George Washington University Law School
(with honors)
B.A., 1996
University of California, Los Angeles
(summa cum laude)

教育背景

法学博士, 2000
乔治华盛顿大学法学院
(荣誉毕业生)
文学学士, 1996
加州大学洛杉矶分校
(最业高荣誉毕业生)

Admissions

Bar

Hong Kong SAR
California

执业资格

司法區

香港
加利福尼亞州
Get In Touch
German Translation
NOUS CONTACTER
联系我们
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.

客户信赖我们世界一流的咨询服务,希望获得针对复杂事务性工作与高风险诉讼的建议。我们通过协作式、跨领域的工作方法来解决客户最棘手的问题,涵盖金融、生命科学、私募股权、不动产和技术等多个行业。如需更多信息,请与我们联系。

Search Other Lawyers
ANWALTSSUCHE
Recherche par Pratique
搜寻其他律师